Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01315392
Other study ID # OTAOREF2000MJB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2000

Study information

Verified date March 2011
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Delayed wound closure is considered by many to be the standard of care for the treatment of an open fracture. This study was conducted to determine the feasibility of a large multi-center prospective randomized clinical trial and collect the pilot data needed to compete for the funding for such a trial. The study was designed to compare immediate and delayed closure of Gustilo type II and IIIa tibia diaphyseal fractures. The primary outcomes were the infection rates and fracture related complications in patients treated with immediate or delayed wound closure strategies.


Recruitment information / eligibility

Status Completed
Enrollment 451
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: - Gustilo type II-IIIa tibia fracture - age greater than 15 years - fractures amenable to intramedullary nailing Exclusion Criteria: - excessive wound contamination - patient cardio-pulmonary or hemodynamic instability preventing prompt surgical intervention - impaired or absent consciousness - refusal of consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
delayed closure
wounds packed open with normal saline wet to dry gauze dressings and were returned to the operating room 36 to 72 hours after initial procedure for a second debridement and definitive closure.
immediate wound closure
traumatic and surgical wounds closed at the initial surgical intervention

Locations

Country Name City State
United States Carolinas Medical Center Charlotte North Carolina

Sponsors (3)

Lead Sponsor Collaborator
Wake Forest University Health Sciences Orthopaedic Research and Education Fund, Orthopaedic Trauma Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary infection rate defined as cases determined definitively by a positive culture or treated empirically based on tenderness, erythema, and heat at the wound site.
Primary hospital readmissions need for additional procedures and hospital readmissions related to the index injury will be documented
Primary tibial fracture healing evidence of bridging callus on three of four cortices assessed by biplanar radiograph